EarningsQ4 2020 Earnings Report

Lakefront Biotherapeutics NV (GLPGN) Q4 2020 Earnings Report

― Followers

MX:GLPGN Q4 2020 EPS Results

Actual EPS-$19.87

Consensus EPS―

Beat/Miss―

One Year Ago EPS-$43.24

Actual Revenue$2.97B

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+21.13%

QuarterQ4 2020

Date02/18/2021

TimeAfter Close

Conference CallThursday, February 18, 2021

MX:GLPGN Upcoming Earnings

Lakefront Biotherapeutics NV's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q3)	-14.78 / -	-63.214	―
Aug 10, 2026	2026 (Q2)	-14.41 / 0.62	-32.534	101.90% (+33.15)
May 06, 2026	2026 (Q1)	-16.78 / 4.32	-48.389	108.94% (+52.71)
Feb 23, 2026	2025 (Q4)	-2.27 / 244.41	5.951	4007.27% (+238.46)
Nov 05, 2025	2025 (Q3)	-8.44 / -63.21	-15.237	-314.86% (-47.98)
Jul 23, 2025	2025 (Q2)	-4.10 / -32.53	1.441	-2357.14% (-33.98)
Apr 23, 2025	2025 (Q1)	-2.80 / -48.39	7.413	-752.78% (-55.80)
Feb 12, 2025	2024 (Q4)	-10.52 / 5.95	49.212	-87.91% (-43.26)
Oct 30, 2024	2024 (Q3)	-3.19 / -15.24	8.03	-289.74% (-23.27)
Aug 01, 2024	2024 (Q2)	-1.40 / 1.44	1.647	-12.50% (-0.21)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed